NUTEX HEALTH INC (NUTX) Stock Price, Quote, News and Overview
NASDAQ:NUTX - Nasdaq - US67079U3068 - Common Stock - Currency: USD
NUTX Quote, Performance and Key Statistics
177.21
+1 (+0.57%)
The current stock price of NUTX is 177.21 USD. In the past month the price increased by 21.38%. In the past year, price increased by 2276.74%.
NUTX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 11.77 | 88.11B | ||
| CVS | CVS HEALTH CORP | 10.02 | 80.46B | ||
| LH | LABCORP HOLDINGS INC | 17.03 | 20.99B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.39 | 19.90B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 18.89 | 17.52B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 134.11 | 14.56B | ||
| HIMS | HIMS & HERS HEALTH INC | 88.71 | 13.69B | ||
| DVA | DAVITA INC | 15.78 | 11.20B | ||
| CHE | CHEMED CORP | 24.67 | 8.51B | ||
| CRVL | CORVEL CORP | 27.19 | 5.84B | ||
| OPCH | OPTION CARE HEALTH INC | 26.67 | 5.42B | ||
| GH | GUARDANT HEALTH INC | N/A | 4.95B |
Related stock screener links
About NUTX
Company Profile
Nutex Health, Inc. is a technology-enabled healthcare service. The company is headquartered in Houston, Texas and currently employs 800 full-time employees. The company went IPO on 2011-03-18. The firm operates through three segments: The Hospital division, The Population Health Management (PHM) division and The Real Estate division. The Hospital division develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs) providing comprehensive and high-quality 24/7 care. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). The Real Estate division owns the land and hospital buildings which are leased to its hospital entities. The firm also provides limited services to one health maintenance organization (HMO) and two other IPAs in Southern and Northern California. The firm's cloud-based technology platform aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers.
Company Info
NUTEX HEALTH INC
6030 S. Rice Ave., Suite C
Houston TEXAS US
Employees: 800
Phone: 17136600557
NUTEX HEALTH INC / NUTX FAQ
What is the stock price of NUTEX HEALTH INC today?
The current stock price of NUTX is 177.21 USD. The price increased by 0.57% in the last trading session.
What is the ticker symbol for NUTEX HEALTH INC stock?
The exchange symbol of NUTEX HEALTH INC is NUTX and it is listed on the Nasdaq exchange.
On which exchange is NUTX stock listed?
NUTX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NUTEX HEALTH INC stock?
9 analysts have analysed NUTX and the average price target is 104.04 USD. This implies a price decrease of -41.29% is expected in the next year compared to the current price of 177.21. Check the NUTEX HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NUTEX HEALTH INC worth?
NUTEX HEALTH INC (NUTX) has a market capitalization of 979.97M USD. This makes NUTX a Small Cap stock.
How many employees does NUTEX HEALTH INC have?
NUTEX HEALTH INC (NUTX) currently has 800 employees.
Is NUTEX HEALTH INC (NUTX) expected to grow?
The Revenue of NUTEX HEALTH INC (NUTX) is expected to grow by 53.08% in the next year. Check the estimates tab for more information on the NUTX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NUTEX HEALTH INC (NUTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NUTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NUTX, evaluating the profitability, health, valuation and growth aspects
- NUTEX HEALTH INC (NUTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NUTEX HEALTH INC (NUTX) Sales and EPS estimates to see what analysts future expectations are.
- NUTEX HEALTH INC (NUTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NUTEX HEALTH INC (NUTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- NUTEX HEALTH INC (NUTX) Stock Chart to make your own analysis
- NUTEX HEALTH INC (NUTX) Latest news and press-releases to stay up to date.
Does NUTEX HEALTH INC (NUTX) stock pay dividends?
NUTX does not pay a dividend.
When does NUTEX HEALTH INC (NUTX) report earnings?
NUTEX HEALTH INC (NUTX) will report earnings on 2025-08-06.
What is the Price/Earnings (PE) ratio of NUTEX HEALTH INC (NUTX)?
The PE ratio for NUTEX HEALTH INC (NUTX) is 14.9. This is based on the reported non-GAAP earnings per share of 11.89 and the current share price of 177.21 USD. Check the full fundamental report for a full analysis of the valuation metrics for NUTX.
What is the Short Interest ratio of NUTEX HEALTH INC (NUTX) stock?
The outstanding short interest for NUTEX HEALTH INC (NUTX) is 3.49% of its float. Check the ownership tab for more information on the NUTX short interest.
NUTX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to NUTX. When comparing the yearly performance of all stocks, NUTX is one of the better performing stocks in the market, outperforming 99.92% of all stocks.
NUTX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NUTX. NUTX has an average financial health and profitability rating.
NUTX Financial Highlights
Over the last trailing twelve months NUTX reported a non-GAAP Earnings per Share(EPS) of 11.89. The EPS increased by 430.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.87% | ||
| ROA | 7.96% | ||
| ROE | 35.65% | ||
| Debt/Equity | 1.95 |
NUTX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to NUTX. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -36.62% and a revenue growth 53.08% for NUTX